Results 171 to 180 of about 297,465 (360)
Annals of Gastroenterological Surgery, EarlyView.ABSTRACT Aim Serum tumor markers are helpful for diagnosis, monitoring treatment outcomes, and prognosis. However, their clinical utility for esophageal squamous cell carcinoma (ESCC) and gastric cancer (GC) remains unclear. This study aimed to comprehensively evaluate recent studies on serum tumor markers in ESCC and GC.
Yasunori Matsumoto +2 more
wiley +1 more source
Causal association between modifiable risk factors and esophageal cancer: A Mendelian randomization study [PDF]
Xiaoqing Wang +11 more
openalex +1 more source
Annals of Gastroenterological Surgery, EarlyView.ABSTRACT Background Nivolumab‐including chemotherapy (nivo‐CTX) for stage IV gastric cancer (GC) may increase the chance of conversion surgery but risk of immune‐related adverse events (irAEs) during perioperative period remains unclear. Methods We examined irAEs in 36 patients with marginally resectable GC who received nivo‐CTX followed by surgery ...
Masashi Nishino +11 more
wiley +1 more source
Minimally invasive staging of esophageal cancer [PDF]
, 2017 Kunal Mehta +4 more
openalex +1 more source
Annals of Gastroenterological Surgery, EarlyView.We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley +1 more source
Age scope of high-risk population for esophageal cancer in Ci county
, 2005 Zhifeng Chen
openalex +2 more sources
Thoracolaparoscopic esophagectomy for esophageal cancer with a cervical incision to extract specimen
, 2022 Zhihao Hu +7 more
openalex +1 more source